This includes a reduced rate of eczema herpeticum for dupilumab-treated patients compared with placebo, which was significant in adults (RRs 0.31–0.34) [ 74 , 84 ], but did not reach statistical significance in children because of the smaller patient population (RR 0.50) [ 71 ].
← all excerpts
Infections in Patients with Atopic Dermatitis and the Influence of Treatment.
1
—
—